# Vertex Pharmaceuticals Incorporated (VRTX) — Q3-2015 Earnings Results

**Report date:** 2015-10-28 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2015

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Misses on EPS, Stock Down 0.75%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.13 | N/A | +78.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Vertex Pharmaceuticals reported a loss per share of $-0.13, which was better than expected, but the lack of revenue data leaves uncertainty. The stock reacted negatively, declining by 0.75%. Investors may be cautious due to the absence of guidance and further details from the earnings call.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2015_